Mounjaro 5 mg Kwik pen

Prescription dual GIP & GLP-1 receptor agonist for adults with type 2 diabetes

Contains 5mg tirzepatide per dose in a convenient KwikPen device

Administered once weekly for consistent blood sugar management

Clinically proven to help reduce HbA1c levels alongside diet and exercise

Supports appetite control and may assist with weight management under medical supervision

Pre-filled KwikPen injection for accurate, easy self-administration

Long-acting formula for steady glucose control throughout the week

Suitable as a dose escalation step after the starting 2.5mg dose (as prescribed)

Helps improve overall glycemic control in adults with type 2 diabetes

Used under the guidance of a healthcare professional